Free Trial

Novozymes A/S (OTCMKTS:NVZMY) Sets New 1-Year High - Here's What Happened

Novozymes A/S logo with Basic Materials background

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $75.99 and last traded at $75.23, with a volume of 10550 shares trading hands. The stock had previously closed at $74.89.

Novozymes A/S Trading Down 1.7%

The company has a quick ratio of 1.06, a current ratio of 1.73 and a debt-to-equity ratio of 0.14. The company has a market cap of $34.03 billion, a P/E ratio of 45.99 and a beta of 0.92. The business has a 50-day moving average price of $67.68 and a two-hundred day moving average price of $61.11.

About Novozymes A/S

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Further Reading

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines